Johnson & Johnson vs Medtronic plc. — Stock Comparison
Johnson & Johnson (JNJ) and Medtronic plc. (MDT) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Medtronic plc. narrowly edges Johnson & Johnson on Q·Score (7.1 vs 7 out of 10), led by Growth (7.9 vs 5.1) and Valuation (7.7 vs 6.5). Johnson & Johnson scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for MDT (+22.2%) than for JNJ (+5.0%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Earnings growing 17% year-over-year on 10% revenue growth.
Analyst Consensus
Fundamentals
Frequently Asked Questions
JNJ vs MDT: which stock scores better overall?
Based on Q·Score, Medtronic plc. (MDT) scores 7.1/10 versus Johnson & Johnson (JNJ) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: JNJ or MDT?
Medtronic plc. (MDT) scores higher on Growth (7.9/10 vs 5.1/10). Johnson & Johnson reports revenue growth (9.9% YoY) while Medtronic plc. reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is JNJ or MDT more attractively valued?
Medtronic plc. (MDT) scores higher on Valuation (7.7/10 vs 6.5/10). JNJ trades at 18.9× P/E versus MDT at 12.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about JNJ vs MDT?
There are 23 analysts covering JNJ with a consensus price target of $252.87, and 26 analysts covering MDT with a consensus target of $98.00. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: JNJ or MDT?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 6.4/10). Net profit margin: JNJ at 21.8%, MDT at 13.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: JNJ or MDT?
Medtronic plc. (MDT) scores higher on Financial Health (7/10 vs 6.5/10). Market beta: JNJ at 0.26, MDT at 0.60. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of JNJ and MDT?
Johnson & Johnson (JNJ) has a market capitalisation of $579.8B, while Medtronic plc. (MDT) has a market cap of $103.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do JNJ or MDT pay dividends?
JNJ pays a dividend yield of 2.23%, while MDT pays a dividend yield of 3.59%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →